05/21/2024
6:30 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
4:00 PM | SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SKYLER JAY S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
4:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
8:35 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:50 PM | Bausch Christoph Lawrence (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:55 PM | SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:00 PM | Kropotova Alexandra (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/23/2024
3:40 PM | Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:02 AM | RTW INVESTMENTS, LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G | |
02/14/2024
5:28 AM | Radcliffe Capital Management, L.P. (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G/A | |
02/02/2024
6:53 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
3:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 424B5 | |
01/25/2024
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:21 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
8:00 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
8:34 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form DEF 14A | |
12/08/2023
4:26 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form PRE 14A | |
12/08/2023
7:00 AM | SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sullivan Eddie Joe (Reporting)
Sullivan Eddie Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
3:33 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G | |
11/30/2023
4:00 PM | King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
7:00 AM | Reich Samuel J (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
6:40 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
11:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form EFFECT | |
11/22/2023
3:45 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | Ellias Helen K. (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
3:45 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form S-3/A | |
11/15/2023
8:10 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4/A | |
11/15/2023
3:30 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 4/A | |
11/14/2023
6:00 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:50 PM | King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/03/2023
3:40 PM | King Michael (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/27/2023
4:00 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
4:30 PM | Moin Andrew (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
4:33 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
3:30 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form PRE 14A | |
10/16/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
SAB Biotherapeutics, Inc. (Subject)
SAB Biotherapeutics (Subject)
SAB Biotherapeutics, Inc. (Subject)
| Form SC 13G | |
10/16/2023
3:08 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/10/2023
3:24 PM | Petry John (Reporting)
SAB Biotherapeutics, Inc. (Issuer)
SAB Biotherapeutics (Issuer)
SAB Biotherapeutics, Inc. (Issuer)
Sessa Capital , L.P. (0001618360) (Reporting)
Sessa Capital GP, LLC (Reporting)
Sessa Capital IM GP, LLC (Reporting)
Sessa Capital IM, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2023
11:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form EFFECT | |
08/21/2023
3:15 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Shocking $16T Elon Musk Crypto Leak (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
08/21/2023
7:25 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
7:23 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:43 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:19 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form POS AM | |
07/03/2023
12:20 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:05 PM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form RW | |
06/21/2023
7:50 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
7:53 AM | SAB Biotherapeutics, Inc. (Filer)
SAB Biotherapeutics (Filer)
SAB Biotherapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
